GSTP1 and non-small cell lung carcinoma: Therefore, our meta-analysis is more precise and reliable in predicting the role of GSTP1, GSTM1 and GSTT1 polymorphisms on the clinical outcome of platinum-based chemotherapy in NSCLC patients.